Increased volume in the packaging and testing business and higher profit
First written in FY2017-Q1. 14 of 36 entries say "Reframed", first in FY2018-Q2. Latest entry: 2026-08-07.
No other company in this theme has enough history to compare yet.
- 2026-08-07ReframedEarnings
「③ Packaging business Due to higher business volume, revenue was ¥14.841 billion, up 6.3% year on year. Although revenue increased, operating profit fell 2.8% to ¥924 million due to higher personnel expenses and packaging material costs. ④ Testing business Due to lower business volume, revenue was ¥5.528 billion, down 5.7% year on year. In addition to the effect of lower revenue, operating profit fell 54.1% to ¥344 million because of higher costs, including personnel expenses and depreciation of testing equipment.」
The Packaging business posted higher revenue but lower profit due to increased personnel expenses and packaging material costs, while the Testing business recorded lower revenue and profit due to lower business volume and higher costs. - FY2026Higher sales and earnings in both businesses for the full year, with earnings drivers divergingAnnual report
「Packaging Business Net sales were ¥57,648 million, up 0.5% year on year. Operating income was ¥4,429 million, up 4.3%, due to improved operating efficiency and lower outsourcing costs.\nTesting Business Net sales rose 1.7% year on year to ¥24,569 million due to an increase in workload. Operating income was ¥4,016 million, up 0.7%, despite higher personnel expenses and depreciation of new testing equipment.」
Both businesses reported lower income in the first half, but both the Packaging Business and Testing Business reported higher sales and income for the full year. The Packaging Business benefited from efficiency improvements and lower outsourcing costs, while the Testing Business was affected by higher costs. - FY2026-H1ReframedAnnual report
「(Packaging Business) Net sales were ¥28,047 million, down 1.2% year on year, due mainly to a decline in workload at some consolidated subsidiaries. Operating income was ¥1,986 million, down 11.6%, reflecting the decline in net sales and other factors. (Testing Business) Net sales rose 2.2% year on year to ¥11,905 million due to an increase in workload. Operating income was ¥1,690 million, down 5.5%, due to higher personnel expenses and depreciation of testing equipment.」
The Packaging Business reported lower sales and income due to a decline in workload, while the Testing Business reported higher sales but lower income due to increased personnel expenses and depreciation of testing equipment, resulting in divergent profit trends between the two businesses. - FY2025-H1RestatedAnnual report
「(Packaging business) Net sales increased 7.8% year on year to ¥28.393 billion owing to the recovery in business volume, appropriate adjustment of collection fees and other factors. Operating profit increased 50.8% to ¥2.247 billion owing to the effect of higher sales. / (Testing business) Net sales increased 8.0% year on year to ¥11.649 billion owing to the recovery in business volume. Operating profit increased 21.5% to ¥1.789 billion owing to the effect of higher sales.」
Both the Packaging and Testing businesses posted higher sales owing to the recovery in business volume, and higher earnings against a backdrop of the effect of higher sales. - FY2024RestatedAnnual report
「The Packaging business recorded net sales of ¥53.809 billion, up 8.5% year on year, owing to the recovery in business volume and other factors. Operating profit was ¥3.320 billion, up 10.4%, owing to the effect of higher sales and other factors. The Testing business recorded net sales of ¥22.881 billion, up 9.3%, mainly owing to the recovery in business volume. Operating profit was ¥3.329 billion, up 49.7%, owing to the effect of higher sales and improved operating efficiency.」
Both the Packaging and Testing businesses posted higher sales owing to the recovery in business volume, and higher earnings owing to the effect of higher sales and improved operating efficiency. - FY2024-Q3RestatedAnnual report
「(Packaging business) Net sales increased 9.8% year on year to ¥40.274 billion owing to the recovery in business volume and other factors. Operating profit increased 10.0% to ¥2.362 billion owing to improved work efficiency and other factors. (Testing business) Net sales increased 8.6% year on year to ¥16.825 billion, mainly owing to the recovery in business volume. Operating profit increased 72.2% to ¥2.490 billion owing to the effect of higher sales and improved operating efficiency.」
Both the Packaging and Testing businesses posted higher sales against a backdrop of recovering business volume, and higher earnings continued owing to improved work efficiency, the effect of higher sales and improved operating efficiency. - FY2024-Q2RestatedAnnual report
「(Packaging business) Net sales increased 10.3% year on year to ¥26.333 billion owing to the recovery in business volume and other factors. Operating profit increased 34.6% to ¥1.490 billion owing to improved work efficiency and other factors. (Testing business) Net sales increased 5.8% year on year to ¥10.791 billion, mainly owing to the recovery in business volume. Operating profit increased 78.4% to ¥1.472 billion owing to the effect of higher sales and improved operating efficiency.」
Both the Packaging and Testing businesses posted higher sales against a backdrop of recovering business volume, and higher earnings continued owing to improved work efficiency, the effect of higher sales and improved operating efficiency. - FY2024-Q1Recovery in higher sales and earnings in both businessesAnnual report
「(Packaging business) Net sales increased 11.6% year on year to ¥12.811 billion owing to the recovery in business volume and other factors. Operating profit increased 92.1% to ¥662 million owing to improved work efficiency and other factors. (Testing business) Net sales increased 6.1% year on year to ¥5.394 billion, mainly owing to the recovery in business volume. Operating profit increased 78.0% to ¥715 million owing to the effect of higher sales and improved operating efficiency.」
The trend changed from the lower sales and earnings that had continued in the Testing business through the third quarter of the previous fiscal year, with both the Packaging and Testing businesses posting higher sales owing to the recovery in business volume and significant earnings growth. - FY2023-Q3Recovery in higher sales and earnings in the Packaging business and continued lower sales and earnings in the Testing businessAnnual report
「(Packaging business) Net sales increased 12.1% year on year to ¥36.678 billion owing to the recovery in business volume and other factors. Despite higher outsourcing expenses, operating profit increased 7.2% to ¥2.148 billion owing to the effect of higher sales and other factors. (Testing business) Net sales decreased 3.9% year on year to ¥15.492 billion owing to cancellations or postponements of testing work. Operating profit decreased 46.5% to ¥1.446 billion owing to higher personnel and outsourcing expenses and other factors.」
The Packaging business returned to higher sales and earnings owing to the effect of higher sales despite increased outsourcing expenses. The Testing business continued to post lower sales and earnings owing to cancellations and postponements of work and higher personnel and outsourcing expenses. - FY2023-Q2Narrower earnings decline in the Packaging business and continued lower sales and earnings in the Testing businessAnnual report
「(Packaging business) Net sales increased 11.8% year on year to ¥23.874 billion owing to the recovery in business volume and other factors. Operating profit decreased 22.5% to ¥1.107 billion owing to higher personnel and outsourcing expenses and other factors. (Testing business) Net sales decreased 1.6% year on year to ¥10.198 billion owing to cancellations or postponements of testing work due to COVID-19. Operating profit decreased 45.8% to ¥825 million owing to higher personnel and outsourcing expenses and other factors.」
The Packaging business posted higher sales owing to the recovery in business volume, but earnings declined owing to higher personnel and outsourcing expenses, with the year-on-year earnings decline narrower than in the cumulative period through the previous quarter. The Testing business continued to post lower sales and earnings owing to cancellations and postponements of work due to COVID-19 and higher personnel and outsourcing expenses. - FY2023-Q1ReframedAnnual report
「(Packaging business) Net sales increased 5.9% year on year to ¥11.482 billion owing to the recovery in business volume and other factors. Operating profit decreased 57.6% to ¥344 million owing to higher personnel and outsourcing expenses. (Testing business) Net sales decreased 1.1% year on year to ¥5.086 billion owing to the cancellation or postponement of testing work due to COVID-19. Operating profit decreased 45.9% to ¥401 million owing to higher personnel expenses and other factors.」
The Packaging business posted higher sales owing to the recovery in business volume, but earnings declined significantly owing to higher personnel and outsourcing expenses. The Testing business posted lower sales owing to cancellations and postponements of work due to COVID-19, and earnings also declined owing to higher personnel expenses. - FY2022-Q3RestatedAnnual report
「(Packaging business) Net sales increased 11.8% year on year to ¥32.726 billion owing to the recovery in business volume and other factors. Operating profit increased 38.0% to ¥2.004 billion owing to the effect of higher sales and improved operating efficiency. (Testing business) Net sales increased 6.1% year on year to ¥16.120 billion owing to the recovery in business volume and other factors. Operating profit increased 42.6% to ¥2.704 billion owing to the effect of higher sales and improved operating efficiency.」
Both the Packaging and Testing businesses posted higher sales owing to the recovery in business volume, and higher earnings continued against a backdrop of the effect of higher sales and improved operating efficiency. - FY2022-Q2Continued revenue and profit growth in both businessesAnnual report
「(Packaging business) Net sales increased 16.1% year on year to ¥21.351 billion owing to the recovery in business volume and other factors. Operating profit increased 249.7% to ¥1.428 billion owing to the effect of higher sales and improved operating efficiency. (Testing business) Net sales increased 3.9% year on year to ¥10.360 billion owing to the recovery in business volume and other factors. Operating profit increased 32.9% to ¥1.521 billion owing to the effect of higher sales and improved operating efficiency.」
Both the Packaging and Testing businesses posted higher sales owing to the recovery in business volume, and higher earnings continued against a backdrop of the effect of higher sales and improved efficiency. - FY2022-Q1Recovery in business volume and higher earnings in both businessesAnnual report
「(Packaging business) Net sales increased 17.2% year on year to ¥21.845 billion owing to the recovery in business volume and other factors. Despite higher fuel prices, operating profit increased 208.2% to ¥1.192 billion owing to the effect of higher sales and improved transportation efficiency.」
The Packaging business posted higher sales owing to the recovery in business volume, and operating profit also increased against a backdrop of the effect of higher sales and improved operating efficiency. The Testing business also posted higher sales owing to the recovery in business volume, while operating profit increased 49.5% year on year. - FY2021Lower sales and earnings in both businesses for the full year, with narrower earnings declinesAnnual report
「The Packaging business recorded net sales of ¥40.136 billion, down 14.4% year on year, as business volume declined significantly owing to the spread of COVID-19 and other factors. Although personnel and outsourcing expenses declined, operating profit was ¥2.365 billion, down 36.2%, owing to the effect of lower sales. The Testing business recorded net sales of ¥20.463 billion, down 7.9%, as business volume declined owing to the spread of COVID-19 and other factors. Operating profit was ¥2.809 billion, down 29.8%, owing to lower sales and higher depreciation expenses for the research and development building that began operations in April of the previous year.」
Both the Packaging and Testing businesses posted lower sales and earnings for the full year, but the rates of operating profit decline narrowed in both businesses compared with the nine months ended the third quarter. - FY2021-Q3Narrower earnings declines in both businessesAnnual report
「(Packaging business) As business volume in Japan and overseas declined significantly owing to the spread of COVID-19 and other factors, net sales decreased 17.7% year on year to ¥29.273 billion. Although personnel and outsourcing expenses declined, operating profit decreased 45.9% to ¥1.452 billion owing to the effect of lower sales. (Testing business) Testing business volume declined owing to the spread of COVID-19 and other factors, and net sales decreased 8.7% year on year to ¥15.197 billion. Operating profit decreased 34.9% to ¥1.896 billion owing to lower sales and higher depreciation expenses for the research and development building that began operations in April of the previous year.」
Both the Packaging and Testing businesses continued to post lower sales and earnings, but the year-on-year rates of earnings decline were lower than in the cumulative period through the previous quarter. In the Packaging business, personnel and outsourcing expenses declined, but the effect of lower sales weighed on earnings. - FY2021-Q2Improved earnings in the Packaging business and a narrower earnings decline in the Testing businessAnnual report
「As business volume in Japan and overseas declined significantly owing to the spread of COVID-19 and other factors, net sales decreased 23.6% year on year to ¥18.388 billion. Despite reductions in personnel and outsourcing expenses, operating profit decreased 78.1% to ¥408 million owing to the effect of lower sales. Testing business volume declined owing to the spread of COVID-19 and other factors, and net sales decreased 11.7% year on year to ¥9.969 billion. Operating profit decreased 46.7% to ¥1.144 billion owing to lower sales and higher depreciation expenses for the research and development building that began operations in April of the current year.」
Both the Packaging and Testing businesses continued to post lower sales and earnings, but the Packaging business moved from an operating loss in the cumulative period through the previous quarter to an operating profit, while the decline in Testing earnings narrowed from the previous quarter. - FY2021-Q1ReframedAnnual report
「(Packaging business) As business volume in Japan and overseas declined significantly owing to the spread of COVID-19 and other factors, net sales decreased 29.2% year on year to ¥8.594 billion. Despite reductions in personnel and outsourcing expenses, operating profit was a loss of ¥23 million. (Testing business) Testing business volume declined owing to the spread of COVID-19 and other factors, and net sales decreased 13.4% year on year to ¥4.866 billion. Operating profit decreased 53.1% to ¥497 million owing to lower sales and higher depreciation expenses for the research and development building that began operations in April of the current year.」
The Packaging business posted lower sales owing to a significant decline in business volume and moved into an operating loss, while the Testing business also posted lower sales and earnings owing to lower business volume and higher depreciation expenses for the research and development building. - FY2020ReframedAnnual report
「Packaging business Net sales decreased 0.6% year on year to ¥46.882 billion, mainly owing to lower business volume related to automobiles. Operating profit decreased 7.4% to ¥3.705 billion owing to the effect of lower sales and other factors. Testing business As business volume remained at approximately the previous year’s level, net sales decreased by ¥3 million year on year to ¥22.209 billion. Operating profit increased 2.5% to ¥4.001 billion owing to improved operating efficiency and other factors.」
The Packaging business posted lower sales and earnings owing to lower business volume related to automobiles, while the Testing business posted higher earnings through improved operating efficiency despite business volume remaining approximately at the previous year’s level, resulting in divergent trends between the two businesses. - FY2020-Q3ReframedAnnual report
「(Packaging business) Net sales increased 1.5% year on year to ¥35.561 billion owing to higher business volume and other factors. Operating profit decreased 6.5% to ¥2.682 billion owing to higher personnel and outsourcing expenses associated with increased staffing and other factors. (Testing business) Net sales increased 1.4% year on year to ¥16.641 billion owing to higher business volume and other factors. Operating profit increased 4.8% to ¥2.910 billion owing to the effect of higher sales and improved operating efficiency.」
The Packaging business continued to post higher sales owing to increased business volume, but earnings declined owing to higher personnel and outsourcing expenses. The Testing business posted higher earnings owing to the effect of higher sales and improved operating efficiency, resulting in renewed divergence in earnings trends between the two businesses. - FY2020-Q2RestatedAnnual report
「(Packaging business) Net sales increased 5.8% year on year to ¥24.053 billion owing to higher business volume. Operating profit increased 9.2% to ¥1.862 billion owing to improved operating efficiency and other factors. (Testing business) Net sales increased 5.5% year on year to ¥11.290 billion owing to higher business volume. Operating profit increased 32.4% to ¥2.149 billion owing to the effect of higher sales, improved operating efficiency and other factors.」
Both the Packaging and Testing businesses recorded higher sales owing to increased business volume and higher earnings against a backdrop of improved efficiency and the effect of higher sales. - FY2020-Q1ReframedAnnual report
「(Packaging business) Net sales increased 8.5% year on year to ¥12.132 billion owing to higher business volume. Operating profit increased 22.5% to ¥935 million owing to improved operating efficiency and other factors. (Testing business) Net sales increased 5.0% year on year to ¥5.620 billion owing to higher business volume. Operating profit increased 27.5% to ¥1.060 billion owing to the effect of higher sales, improved operating efficiency and other factors.」
While earnings declined in the first through third quarters of the previous fiscal year owing to higher personnel expenses and other factors, both the Packaging and Testing businesses posted higher sales and earnings in the current quarter, reflecting higher business volume, improved efficiency and the effect of higher sales. - FY2019ReframedAnnual report
「Packaging business Net sales increased 6.9% year on year to ¥47.148 billion owing to higher business volume. Despite higher outsourcing costs and other factors, operating profit increased 2.0% to ¥4.001 billion owing to the effect of higher sales and improved operating efficiency. Testing business Net sales increased 2.7% year on year to ¥22.213 billion owing to higher business volume. Operating profit increased 2.0% to ¥3.902 billion owing to the effect of higher sales and other factors.」
The Packaging and Testing businesses, whose earnings had declined owing to higher personnel expenses and other factors in the first through third quarters, both posted higher sales and earnings for the full year. - FY2019-Q3RestatedAnnual report
「(Packaging business) Net sales increased 6.6% year on year to ¥35.032 billion owing to higher business volume. Operating profit decreased 3.3% to ¥2.869 billion owing to higher personnel and outsourcing expenses and other factors. (Testing business) Net sales increased 1.3% year on year to ¥16.410 billion owing to higher business volume. Operating profit decreased 3.2% to ¥2.777 billion owing to higher personnel expenses associated with an increase in staff and other factors.」
Both the Packaging and Testing businesses recorded higher sales owing to increased business volume, while earnings declines owing to higher personnel expenses and other factors continued. The rates of decline were lower than in the cumulative period through the previous quarter. - FY2019-Q2ReframedAnnual report
「(Packaging business) Net sales increased 6.6% year on year to ¥22.740 billion owing to higher business volume. Operating profit decreased 5.9% to ¥1.705 billion owing to higher personnel and outsourcing expenses and other factors. (Testing business) Net sales increased 1.6% year on year to ¥10.698 billion owing to higher business volume. Operating profit decreased 12.2% to ¥1.623 billion owing to higher personnel expenses associated with an increase in staff and other factors.」
Both the Packaging and Testing businesses recorded higher sales owing to increased business volume, but earnings declines owing to higher personnel expenses and other factors continued, with the rates of decline greater than in the previous quarter. - FY2019-Q1ReframedAnnual report
「c. Packaging business Net sales increased 5.6% year on year to ¥11.186 billion owing to higher business volume. Operating profit decreased 2.8% to ¥763 million owing to higher personnel and outsourcing expenses and other factors. d. Testing business Net sales increased 2.1% year on year to ¥5.353 billion owing to higher business volume. Operating profit decreased 9.0% to ¥831 million owing to higher personnel expenses associated with an increase in staff and other factors.」
Both the Packaging and Testing businesses recorded higher sales owing to increased business volume, while operating profit declined owing to higher personnel and outsourcing expenses and higher personnel expenses associated with increased staffing, resulting in a change in earnings trends. - FY2018RestatedAnnual report
「The Transportation business recorded net sales of ¥88.771 billion, up 3.9%, and operating profit of ¥4.782 billion, up 10.5%. The Warehousing business recorded net sales of ¥27.721 billion, up 4.6%, and operating profit of ¥5.980 billion, up 2.4%. The Packaging business recorded net sales of ¥44.089 billion, up 4.6%, and operating profit of ¥3.921 billion, up 4.1%. The Testing business recorded net sales of ¥21.620 billion, up 9.1%, and operating profit of ¥3.824 billion, up 8.9%.」
For the full year, all 4 major businesses—Transportation, Warehousing, Packaging and Testing—recorded higher sales and earnings, eliminating in the full-year results the divergence in business-level earnings trends observed through the previous quarter. - FY2018-Q3ReframedAnnual report
「③ Packaging business Net sales increased 4.2% year on year to ¥32.854 billion owing to higher business volume. Operating profit increased 12.6% to ¥2.967 billion, owing to the effect of higher sales. ④ Testing business Net sales increased 11.1% year on year to ¥16.198 billion owing to higher business volume. Operating profit increased 10.9% to ¥2.868 billion, owing to the effect of higher sales and other factors.」
The Packaging business, whose operating profit declined slightly in the previous quarter, returned to 12.6% earnings growth owing to the effect of higher sales, while operating profit increased in both businesses together with the Testing business. - FY2018-Q2ReframedAnnual report
「③ Packaging business Net sales increased 4.7% year on year to ¥21.335 billion owing to higher business volume. Operating profit decreased 0.4% to ¥1.812 billion. ④ Testing business Net sales increased 9.6% year on year to ¥10.525 billion owing to higher business volume. Operating profit increased 10.6% to ¥1.848 billion, owing to the effect of higher sales and other factors.」
The Packaging business continued to post higher sales owing to increased business volume, but operating profit decreased 0.4%, while the Testing business posted a 10.6% increase in operating profit owing to the effect of higher sales, resulting in divergent earnings trends between the two businesses. - FY2018-Q1RestatedAnnual report
「③ Packaging business Net sales increased 3.2% year on year to ¥10.598 billion owing to higher business volume. Operating profit increased 1.7% to ¥785 million, owing to the effect of higher sales. ④ Testing business Net sales increased 9.2% year on year to ¥5.245 billion owing to higher business volume. Operating profit increased 4.0% to ¥913 million, owing to the effect of higher sales.」
The Packaging and Testing businesses continued to post higher sales against a backdrop of higher business volume, and operating profit also increased owing to the effect of higher sales. - FY2017RestatedAnnual report
「③ Packaging business Net sales increased 7.1% year on year to ¥42.132 billion owing to higher business volume. Operating profit increased 21.9% to ¥3.768 billion, owing to the effect of higher sales and improved operating efficiency. ④ Testing business Net sales increased 8.8% year on year to ¥19.811 billion owing to higher business volume. Operating profit increased 15.6% to ¥3.511 billion, owing to the effect of higher sales and other factors.」
For the full year, both the Packaging and Testing businesses recorded higher sales against a backdrop of higher business volume, while operating profit increased 21.9% and 15.6%, respectively. - FY2017-Q3RestatedAnnual report
「Net sales increased 9.3% year on year to ¥31.533 billion owing to higher business volume. Operating profit increased 25.4% to ¥2.635 billion, owing to the effect of higher sales and improved operating efficiency. Net sales increased 10.7% year on year to ¥14.582 billion owing to higher business volume. Operating profit increased 33.1% to ¥2.586 billion, owing to the effect of higher sales and other factors.」
The Packaging and Testing businesses continued to post higher sales against a backdrop of higher business volume, while operating profit increased 25.4% and 33.1%, respectively. - FY2017-Q2RestatedAnnual report
「Net sales increased 9.9% year on year to ¥20.386 billion owing to higher business volume. Operating profit increased 31.0% to ¥1.820 billion, owing to the effect of higher sales and improved operating efficiency. Net sales increased 10.4% year on year to ¥9.602 billion owing to higher business volume. Operating profit increased 31.5% to ¥1.671 billion, owing to the effect of higher sales and other factors.」
The Packaging and Testing businesses both recorded double-digit sales growth against a backdrop of higher business volume, while operating profit increased 31.0% and 31.5%, respectively. - FY2017-Q1First statedAnnual report
「Net sales increased 11.8% year on year to ¥10.270 billion owing to higher business volume. Operating profit increased 34.7% to ¥772 million, owing to the effect of higher sales and improved operating efficiency. Net sales increased 12.2% year on year to ¥4.801 billion owing to higher business volume. Operating profit increased 40.5% to ¥879 million, owing to the effect of higher sales and other factors.」
Both the Packaging and Testing businesses recorded double-digit sales growth against a backdrop of higher business volume, and operating profit also increased significantly.